Unicycive Therapeutics Shares Are Trading Higher After Piper Sandler Initiated Coverage on the Stock With an Overweight Rating and a Price Target of $9
派珀·桑德勒开始对Unicycive Therapeutics进行增持评级,目标股价为9美元,此后,Unicycive Therapeutics的股价走高
Unicycive Therapeutics Shares Are Trading Higher After Piper Sandler Initiated Coverage on the Stock With an Overweight Rating and a Price Target of $9
派珀·桑德勒开始对Unicycive Therapeutics进行增持评级,目标股价为9美元,此后,Unicycive Therapeutics的股价走高
使用浏览器的分享功能,分享给你的好友吧